Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
11.07
+0.03 (0.27%)
Feb 4, 2026, 3:04 PM CST
SHE:300485 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 90.81 | 75.26 | 120.16 | 226.21 | 161.54 | 672.53 |
Trading Asset Securities | 1,564 | 1,496 | 1,053 | 895.39 | 1,135 | 507.69 |
Cash & Short-Term Investments | 1,655 | 1,572 | 1,174 | 1,122 | 1,296 | 1,180 |
Cash Growth | 8.23% | 33.92% | 4.63% | -13.47% | 9.82% | -7.68% |
Accounts Receivable | 47.8 | 50.75 | 52.42 | 84.76 | 96.19 | 129.17 |
Other Receivables | 0.99 | 1.43 | 4.01 | 4.08 | 0.98 | 0.95 |
Receivables | 48.79 | 52.19 | 56.43 | 88.84 | 97.17 | 130.12 |
Inventory | 72.7 | 81.37 | 107.06 | 89.09 | 123.05 | 158.64 |
Other Current Assets | 3.76 | 6.47 | 15.99 | 20.91 | 13.83 | 14.52 |
Total Current Assets | 1,780 | 1,712 | 1,353 | 1,320 | 1,530 | 1,484 |
Property, Plant & Equipment | 474.5 | 506.68 | 539.42 | 572.18 | 598.9 | 619.7 |
Long-Term Investments | 944.94 | 957.88 | 1,435 | 1,399 | 1,012 | 635.23 |
Goodwill | 21.87 | 21.87 | 21.87 | 21.87 | 21.87 | 21.87 |
Other Intangible Assets | 44.16 | 47.12 | 49.95 | 53.78 | 58.44 | 61.21 |
Long-Term Deferred Tax Assets | 1.89 | 1.79 | 2.42 | 5.33 | 2.52 | 2.77 |
Long-Term Deferred Charges | 336.23 | 292.71 | 208.97 | 184.07 | 158.55 | 146.95 |
Other Long-Term Assets | 0.73 | 12.16 | 11.79 | 12.12 | 19.01 | 19.83 |
Total Assets | 3,605 | 3,552 | 3,622 | 3,569 | 3,402 | 2,991 |
Accounts Payable | 13.87 | 15.72 | 15.13 | 21.61 | 27.42 | 28.24 |
Accrued Expenses | 4.26 | 39.28 | 15.59 | 31.37 | 33.91 | 74.12 |
Current Income Taxes Payable | 4.78 | 6.59 | - | 0.05 | 0.1 | 0.01 |
Current Unearned Revenue | 5.64 | 5.3 | 6.43 | 9.12 | 12.57 | 11.1 |
Other Current Liabilities | 33.14 | 15.16 | 14.29 | 12.79 | 14.45 | 22.23 |
Total Current Liabilities | 81.68 | 82.05 | 51.45 | 74.94 | 88.46 | 135.7 |
Long-Term Unearned Revenue | 1.44 | 1.24 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 88.14 | 83.18 | 103.16 | 82.16 | 30.08 | 5.42 |
Total Liabilities | 171.26 | 166.48 | 154.61 | 157.1 | 118.54 | 141.13 |
Common Stock | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 |
Additional Paid-In Capital | 845.93 | 828.2 | 828.2 | 845.93 | 843.56 | 838.32 |
Retained Earnings | 2,080 | 2,028 | 2,108 | 2,046 | 1,922 | 1,486 |
Comprehensive Income & Other | 1.02 | 19.19 | 18.65 | 0.33 | -2.62 | -1.87 |
Total Common Equity | 3,409 | 3,357 | 3,436 | 3,374 | 3,245 | 2,804 |
Minority Interest | 24.95 | 28.26 | 31.58 | 38.09 | 38.37 | 45.51 |
Shareholders' Equity | 3,433 | 3,385 | 3,468 | 3,412 | 3,283 | 2,850 |
Total Liabilities & Equity | 3,605 | 3,552 | 3,622 | 3,569 | 3,402 | 2,991 |
Net Cash (Debt) | 1,635 | 1,572 | 1,174 | 1,122 | 1,296 | 1,180 |
Net Cash Growth | 6.92% | 33.92% | 4.63% | -13.47% | 9.82% | -7.68% |
Net Cash Per Share | 3.43 | 3.20 | 2.39 | 2.36 | 2.71 | 2.44 |
Filing Date Shares Outstanding | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 |
Total Common Shares Outstanding | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 | 481.67 |
Working Capital | 1,699 | 1,630 | 1,302 | 1,246 | 1,442 | 1,348 |
Book Value Per Share | 7.08 | 6.97 | 7.13 | 7.00 | 6.74 | 5.82 |
Tangible Book Value | 3,343 | 3,288 | 3,364 | 3,298 | 3,164 | 2,721 |
Tangible Book Value Per Share | 6.94 | 6.83 | 6.98 | 6.85 | 6.57 | 5.65 |
Buildings | - | 511.46 | 511.46 | 510.1 | 451.73 | 455.93 |
Machinery | - | 273.02 | 271.91 | 266.38 | 253.18 | 243.86 |
Construction In Progress | - | 11.03 | 1.05 | 0.33 | 71.06 | 58.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.